In fact, MUC family member has been viewed as ideal target for CAR‐T cells in various cancers: CAR‐T cell therapy specific for MUC1 has been clinically tested in HCC, breast and glioma 25; CAR‐T cells specific for MUC16 have also being investigated in ovarian cancer.26 This evidence concerns the gene MUC16 and central nervous system cancer.